Partial purification of type A and B flagellin from Pseudomonas aeruginosa for preclinical use

https://doi.org/10.53730/ijhs.v6nS1.5590

Authors

  • Mohammed Jaafar Al-Anssari Dept. of Microbiology/ College of Medicine / University of Babylon, Hilla, Iraq and College of Medical and Health Technologies / University of AL-Kafeel, Al-Najaf, Iraq
  • Alaa H. Al-Charrakh Dept. of Microbiology/ College of Medicine / University of Babylon, Hilla, Iraq

Keywords:

Pseudomonas aeruginosa, Flagellin, Purification, Endotoxin Removal, Endotoxin detection, fliC gene

Abstract

Background: Due to their importance in vaccination, we tried in this study to purify the flagellin type a and type b separately from P. aeruginosa by a simple and cheap method with acceptable purity for preclinical use. Methods: Specific primer was used to detect the type a and b flagellin gene (fliC gene) in P. aeruginosa clinical isolates. Flagellin was purified from P. aeruginosa according to standard procedure with some modifications. Protein concentration and protein absorption were measured using a special spectrophotometer at 270 wavelength. Endotoxin removal was done using a special column. Then, the presence of flagellin was detected by SDS-PAGE. Results: The results showed two types of flagllin genes in different strains; type a (1020 bp) and type b (1250 pb) that amplified by PCR. Results also showed an appropriate concentration of purified protein by the used method with acceptable purity and decreasing the endotoxin to an acceptable level for preclinical use (less than 2.2 EU/ml). Conclusion: This research focused on the isolation and purification of flagellin protein from P. aeruginosa.

Downloads

Download data is not yet available.

References

Al Charrakh AH, Al Awadi SJ, Mohammed AS. Detection of metallo-β-lactamase producing Pseudomonas aeruginosa isolated from public and private hospitals in Baghdad, Iraq. 2016;

Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;

Ertugrul BM, Oryasin E, Lipsky BA, Willke A. Virulence genes fliC , toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections Virulence genes fliC , toxA and phzS are common among Pseudomonas aeruginosa isolates from diabetic foot infections. Infect Dis (Auckl). 2017;0(0):1–7.

Prince A. Flagellar activation of epithelial signaling. Am J Respir Cell Mol Biol. 2006;34(5):548–51.

Zhang Y, Deng Q, Barbieri JT. Intracellular localization of type III-delivered Pseudomonas ExoS with endosome vesicles. J Biol Chem. 2007;282(17):13022–32.

Beaudoin T, LaFayette S, Roussel L, Bérubé J, Desrosiers M, Nguyen D, et al. The level of p38$α$ mitogen-activated protein kinase activation in airway epithelial cells determines the onset of innate immune responses to planktonic and biofilm Pseudomonas aeruginosa. J Infect Dis. 2013;207(10):1544–55.

Descamps D, Le Gars M, Balloy V, Barbier D, Maschalidi S, Tohme M, et al. Toll-like receptor 5 (TLR5), IL-1β secretion, and asparagine endopeptidase are critical factors for alveolar macrophage phagocytosis and bacterial killing. Proc Natl Acad Sci U S A. 2012;

Wei H-L, Chakravarthy S, Worley JN, Collmer A. Consequences of flagellin export through the type III secretion system of P seudomonas syringae reveal a major difference in the innate immune systems of mammals and the model plant N icotiana benthamiana. Cell Microbiol. 2013;15(4):601–18.

Ince D, Sutterwala FS, Yahr TL. Secretion of flagellar proteins by the Pseudomonas aeruginosa type III secretion-injectisome system. J Bacteriol. 2015;197(12):2003–11.

Amiel E, Lovewell RR, O’Toole GA, Hogan DA, Berwin B. Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun. 2010;78(7):2937–45.

Zare A, Keshavarzmehr M, Afshar Z, Aleyasin N, Banadkoki AZ, Keshavarzmehr M, et al. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection. Biologicals. 2016 Sep;44(5):367–73.

Korpi F, Hashemi FB, Irajian G, Fatemi MJ, Laghaei P, Behrouz B. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model. Immunol Lett. 2016 Aug;176:8–17.

Behrouz B, Hashemi FB, Fatemi MJ, Naghavi S, Irajian G, Halabian R, et al. Immunization with bivalent flagellin protects mice against fatal Pseudomonas aeruginosa pneumonia. J Immunol Res. 2017;2017:1–17.

Allison JS, Dawson M, Drake D, Montie TC. Electrophoretic separation and molecular weight characterization of Pseudomonas aeruginosa H-antigen flagellins. Infect Immun. 1985;49(3):770–4.

Faezi S, Safarloo M, Amirmozafari N, Nikokar I, Siadat SD, Holder IA, et al. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection. Apmis. 2014;122(2):115–27.

Forbes BA, Sahm DF, Weissfeld AS, others. Diagnostic microbiology. Mosby St Louis; 2007.

Khani MH, Bagheri M. Introducing a cost-effective method for purification of bioactive flagellin from several flagellated gram-negative bacteria. Protein Expr Purif. 2018;155:48–53.

Thermo. Pierce TM Protein Concentrators , PES. USA; 2019.

Needham BD, Trent MS. Fortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis. Nat Rev Microbiol. 2013;11(7):467–81.

Brito LA, Singh M. COMMENTARY: Acceptable Levels of Endotoxin in Vaccine Formulations During Preclinical Research. J Pharm Sci. 2011 Jan;100(1):34–7.

Pierce High-Capacity Endotoxin Removal Resin. USA; Available from: https://assets.thermofisher.com/TFS-Assets/LSG/manuals/MAN0016351_2162373_PierceHighCapacityEndotoxRemovalResin_UG.pdf

Pierce Chromogenic Endotoxin Quant Kit. USA; 2018.

Chromogenic P, Quant E, Endotoxin C, Kit Q. A highly sensitive assay for endotoxin detection and quantitation for a variety of sample types.

Chang SKC, Zhang Y. Protein Analysis. In: Nielsen SS, editor. Food Analysis . Cham: Springer International Publishing; 2017. p. 315–31.

Verma A, Schirm M, Arora SK, Thibault P, Logan SM, Ramphal R. Glycosylation of b-type flagellin of Pseudomonas aeruginosa: Structural and genetic basis. J Bacteriol. 2006;188(12):4395–403.

Published

07-04-2022

How to Cite

Al-Anssari, M. J. ., & Al-Charrakh, A. H. (2022). Partial purification of type A and B flagellin from Pseudomonas aeruginosa for preclinical use. International Journal of Health Sciences, 6(S1), 3661–3670. https://doi.org/10.53730/ijhs.v6nS1.5590

Issue

Section

Peer Review Articles